AZN logo

AstraZeneca (AZN) Gross Profit

Annual Gross Profit

$37.54 B
+$5.58 B+17.47%

December 31, 2023

Summary

Performance

1-Year Change

+17.47%

3-Year Change

+76.11%

5-Year Change

+118.86%

15-Year Change

+106.88%

AZN Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.02%
AZN annual gross profit is higher than 99.02% of companies in Healthcare sector

High & Low

All-time High

$37.54 B
AZN annual gross profit is currently at an all-time high

3-Year Low

$24.98 B
AZN annual gross profit is currently +50.29% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
AZN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 6, 2025
AZN next annual earnings announcement is scheduled for Feb 6, 2025

OtherAZNprofitabilitymetrics:

Annual Gross Margin

81.95%
AZN annual gross profit margin is 81.95%

Annual Revenue

$45.81 B
AZN annual revenue is $45.81 billion

Annual Net Income

$5.96 B
AZN annual net profit is $5.96 billion

Annual EPS

$1.91
AZN annual earnings per share is $1.91

Quarterly Gross Profit

$10.48 B
-$271.00 M-2.52%

September 30, 2024

Summary

Performance

3-Month Change

-2.52%

1-Year Change

+11.57%

3-Year Change

+34.88%

5-Year Change

+34.88%

AZN Quarterly Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

98.97%
AZN quarterly gross profit is higher than 98.97% of companies in Healthcare sector

High & Low

All-time High

$10.76 B
AZN quarterly gross profit is currently -2.52% below its historical high of $10.76 billion

3-Year Low

$7.39 B
AZN quarterly gross profit is currently +41.94% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AZN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 6, 2025
AZN next earnings announcement is scheduled for Feb 6, 2025

OtherAZNprofitabilitymetrics:

Quarterly Gross Margin

77.29%
AZN quarterly gross profit margin is 77.29%

Quarterly Revenue

$13.56 B
AZN quarterly revenue is $13.56 billion

Quarterly Net Income

$1.43 B
AZN quarterly net profit is $1.43 billion

Quarterly EPS

$0.46
AZN quarterly earnings per share is $0.46

TTM Gross Profit

$41.42 B
+$1.09 B+2.70%

September 30, 2024

Summary

Performance

3-Month Change

+2.7%

1-Year Change

+14.62%

3-Year Change

+42.09%

5-Year Change

+42.09%

AZN TTM Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.26%
AZN TTM gross profit is higher than 99.26% of companies in Healthcare sector

High & Low

All-time High

$41.42 B
AZN TTM gross profit is currently at an all-time high

3-Year Low

$24.98 B
AZN TTM gross profit is currently +65.80% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AZN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 6, 2025
AZN next earnings announcement is scheduled for Feb 6, 2025

OtherAZNprofitabilitymetrics:

Annual Gross Margin

81.95%
AZN annual gross profit margin is 81.95%

TTM Revenue

$51.21 B
AZN TTM revenue is $51.21 billion

TTM Net Income

$6.50 B
AZN TTM net profit is $6.50 billion

TTM EPS

$2.08
AZN TTM earnings per share is $2.08

Gross Profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

Annual Gross Profit

$37.54 B
AZN annual gross profit is $37.54 billion

Annual Revenue

$45.81 B
AZN annual revenue is $45.81 billion

Annual Cost Of Goods Sold

$8.27 B
AZN annual cost of goods sold is $8.27 billion

AZN Gross Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+17.5%+11.6%+14.6%
3 y3 years+76.1%+34.9%+42.1%
5 y5 years+118.9%+34.9%+42.1%

AZN Gross Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+50.3%-2.5%+41.9%at high+65.8%
5 y5-yearat high+92.9%-2.5%+112.5%at high+112.8%
alltimeall timeat high+304.3%-2.5%+880.6%at high+3773.9%

AstraZeneca Gross Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
$10.48 B(-2.5%)
$41.42 B(+2.7%)
Jun 2024
-
$10.76 B(+2.8%)
$40.33 B(+3.3%)
Mar 2024
-
$10.46 B(+7.7%)
$39.03 B(+4.0%)
Dec 2023
$37.54 B(+17.5%)
$9.72 B(+3.4%)
$37.54 B(+3.9%)
Sep 2023
-
$9.40 B(-0.6%)
$36.13 B(+4.0%)
Jun 2023
-
$9.46 B(+5.4%)
$34.74 B(+5.1%)
Mar 2023
-
$8.97 B(+8.0%)
$33.05 B(+3.4%)
Dec 2022
$31.96 B(+27.9%)
$8.31 B(+3.8%)
$31.96 B(+3.0%)
Sep 2022
-
$8.00 B(+2.9%)
$31.04 B(+6.5%)
Jun 2022
-
$7.77 B(-1.3%)
$29.15 B(+6.4%)
Mar 2022
-
$7.88 B(+6.7%)
$27.40 B(+9.7%)
Dec 2021
$24.98 B(+17.2%)
$7.39 B(+20.9%)
$24.98 B(+6.4%)
Sep 2021
-
$6.11 B(+1.3%)
$23.48 B(+4.0%)
Jun 2021
-
$6.03 B(+10.5%)
$22.58 B(+3.4%)
Mar 2021
-
$5.46 B(-7.3%)
$21.84 B(+2.4%)
Dec 2020
$21.32 B(+9.5%)
$5.88 B(+13.0%)
$21.32 B(+2.9%)
Sep 2020
-
$5.21 B(-1.6%)
$20.72 B(+0.7%)
Jun 2020
-
$5.29 B(+7.2%)
$20.57 B(+2.7%)
Mar 2020
-
$4.93 B(-6.7%)
$20.04 B(+2.9%)
Dec 2019
$19.46 B(+13.5%)
$5.29 B(+4.6%)
$19.46 B(+2.7%)
Sep 2019
-
$5.05 B(+6.2%)
$18.96 B(+4.8%)
Jun 2019
-
$4.76 B(+9.1%)
$18.09 B(+3.5%)
Mar 2019
-
$4.36 B(-8.7%)
$17.47 B(+1.9%)
Dec 2018
$17.15 B(-5.5%)
$4.78 B(+14.2%)
$17.15 B(+1.3%)
Sep 2018
-
$4.19 B(+1.1%)
$16.93 B(-4.5%)
Jun 2018
-
$4.14 B(+2.4%)
$17.72 B(+0.2%)
Mar 2018
-
$4.04 B(-11.2%)
$17.68 B(-2.6%)
Dec 2017
$18.15 B(-3.9%)
$4.55 B(-8.6%)
$18.15 B(+0.7%)
Sep 2017
-
$4.98 B(+21.5%)
$18.02 B(+1.0%)
Jun 2017
-
$4.10 B(-9.1%)
$17.84 B(-2.4%)
Mar 2017
-
$4.51 B(+1.9%)
$18.28 B(-3.2%)
Dec 2016
$18.88 B(-5.9%)
$4.42 B(-7.8%)
$18.88 B(-3.6%)
Sep 2016
-
$4.80 B(+5.7%)
$19.58 B(-0.5%)
Jun 2016
-
$4.54 B(-11.2%)
$19.69 B(-3.4%)
Mar 2016
-
$5.11 B(-0.4%)
$20.39 B(+1.6%)
Dec 2015
$20.06 B(-3.1%)
$5.13 B(+4.6%)
$20.06 B(+0.4%)
Sep 2015
-
$4.90 B(-6.4%)
$19.98 B(-1.4%)
Jun 2015
-
$5.24 B(+9.4%)
$20.27 B(-1.0%)
Mar 2015
-
$4.79 B(-5.2%)
$20.49 B(-1.1%)
Dec 2014
$20.70 B(+0.8%)
$5.05 B(-2.8%)
$20.70 B(-2.1%)
Sep 2014
-
$5.19 B(-4.8%)
$21.16 B(+0.9%)
Jun 2014
-
$5.46 B(+8.9%)
$20.97 B(+2.6%)
Mar 2014
-
$5.01 B(-8.9%)
$20.43 B(-0.5%)
Dec 2013
$20.55 B(-9.0%)
$5.50 B(+9.7%)
$20.55 B(-1.8%)
Sep 2013
-
$5.01 B(+2.0%)
$20.93 B(-1.9%)
Jun 2013
-
$4.92 B(-4.0%)
$21.33 B(-1.8%)
Mar 2013
-
$5.12 B(-13.0%)
$21.73 B(-3.8%)
Dec 2012
$22.58 B(-18.1%)
$5.88 B(+8.8%)
$22.58 B(-4.9%)
Sep 2012
-
$5.41 B(+1.8%)
$23.74 B(-4.9%)
Jun 2012
-
$5.31 B(-11.0%)
$24.95 B(-6.1%)
Mar 2012
-
$5.97 B(-15.2%)
$26.59 B(-3.6%)
Dec 2011
$27.57 B
$7.04 B(+6.4%)
$27.57 B(+0.7%)
DateAnnualQuarterlyTTM
Sep 2011
-
$6.62 B(-4.7%)
$27.38 B(+0.9%)
Jun 2011
-
$6.95 B(-0.1%)
$27.13 B(+0.8%)
Mar 2011
-
$6.95 B(+1.4%)
$26.91 B(+0.1%)
Dec 2010
$26.88 B(-0.6%)
$6.86 B(+7.6%)
$26.88 B(-1.5%)
Sep 2010
-
$6.37 B(-5.2%)
$27.30 B(-2.0%)
Jun 2010
-
$6.73 B(-2.8%)
$27.86 B(+0.8%)
Mar 2010
-
$6.92 B(-4.9%)
$27.63 B(+2.2%)
Dec 2009
$27.03 B(+8.1%)
$7.28 B(+4.9%)
$27.03 B(+4.6%)
Sep 2009
-
$6.94 B(+6.8%)
$25.83 B(+3.0%)
Jun 2009
-
$6.49 B(+2.8%)
$25.08 B(-0.1%)
Mar 2009
-
$6.32 B(+3.9%)
$25.11 B(+0.4%)
Dec 2008
$25.00 B(+8.1%)
$6.08 B(-1.8%)
$25.00 B(+0.2%)
Sep 2008
-
$6.19 B(-5.1%)
$24.95 B(+1.8%)
Jun 2008
-
$6.53 B(+5.1%)
$24.51 B(+3.0%)
Mar 2008
-
$6.21 B(+3.0%)
$23.79 B(+2.8%)
Dec 2007
$23.14 B(+10.6%)
$6.03 B(+4.9%)
$23.14 B(+2.0%)
Sep 2007
-
$5.75 B(-1.0%)
$22.69 B(+2.6%)
Jun 2007
-
$5.80 B(+4.4%)
$22.12 B(+2.4%)
Mar 2007
-
$5.56 B(-0.3%)
$21.60 B(+3.3%)
Dec 2006
$20.92 B(+12.5%)
$5.58 B(+7.7%)
$20.92 B(+3.4%)
Sep 2006
-
$5.18 B(-2.1%)
$20.24 B(+3.2%)
Jun 2006
-
$5.29 B(+8.5%)
$19.61 B(+2.5%)
Mar 2006
-
$4.88 B(-0.5%)
$19.14 B(+2.9%)
Dec 2005
$18.59 B(+14.5%)
$4.90 B(+7.8%)
$18.59 B(+3.3%)
Sep 2005
-
$4.54 B(-5.7%)
$18.00 B(+3.2%)
Jun 2005
-
$4.82 B(+11.2%)
$17.43 B(+4.7%)
Mar 2005
-
$4.33 B(+0.7%)
$16.65 B(+2.6%)
Dec 2004
$16.23 B(+12.8%)
$4.30 B(+8.1%)
$16.23 B(+3.0%)
Sep 2004
-
$3.98 B(-1.4%)
$15.76 B(+2.4%)
Jun 2004
-
$4.04 B(+3.1%)
$15.39 B(+4.7%)
Mar 2004
-
$3.92 B(+2.4%)
$14.70 B(+2.2%)
Dec 2003
$14.39 B(+8.0%)
$3.82 B(+6.0%)
$14.39 B(+1.1%)
Sep 2003
-
$3.61 B(+7.8%)
$14.23 B(+3.3%)
Jun 2003
-
$3.35 B(-7.2%)
$13.77 B(+0.7%)
Mar 2003
-
$3.61 B(-1.7%)
$13.67 B(+2.7%)
Dec 2002
$13.32 B(+10.8%)
$3.67 B(+16.6%)
$13.32 B(+3.4%)
Sep 2002
-
$3.15 B(-3.2%)
$12.89 B(+2.1%)
Jun 2002
-
$3.25 B(0.0%)
$12.62 B(+2.1%)
Mar 2002
-
$3.25 B(+0.6%)
$12.36 B(+2.9%)
Dec 2001
$12.02 B(+1.2%)
$3.23 B(+12.1%)
$12.01 B(+36.8%)
Sep 2001
-
$2.89 B(-3.4%)
$8.78 B(+0.8%)
Jun 2001
-
$2.99 B(+2.7%)
$8.71 B(+0.3%)
Mar 2001
-
$2.91 B(+3.1%)
$8.69 B(-19.8%)
Sep 2000
-
$2.82 B(-4.9%)
$10.83 B(-1.9%)
Jun 2000
-
$2.96 B(+5.2%)
$11.04 B(-3.1%)
Mar 2000
-
$2.82 B(+26.2%)
$11.39 B(+32.9%)
Dec 1999
$11.89 B(+28.0%)
$2.23 B(-26.2%)
$8.57 B(+35.2%)
Sep 1999
-
$3.03 B(-8.7%)
$6.34 B(+91.3%)
Jun 1999
-
$3.31 B(+40.1%)
$3.31 B(+40.1%)
Dec 1998
$9.29 B
-
-
Jun 1998
-
$2.37 B(+121.2%)
$2.37 B(+121.2%)
Jun 1995
-
$1.07 B
$1.07 B

FAQ

  • What is AstraZeneca annual gross profit?
  • What is the all time high annual gross profit for AstraZeneca?
  • What is AstraZeneca annual gross profit year-on-year change?
  • What is AstraZeneca quarterly gross profit?
  • What is the all time high quarterly gross profit for AstraZeneca?
  • What is AstraZeneca quarterly gross profit year-on-year change?
  • What is AstraZeneca TTM gross profit?
  • What is the all time high TTM gross profit for AstraZeneca?
  • What is AstraZeneca TTM gross profit year-on-year change?

What is AstraZeneca annual gross profit?

The current annual gross profit of AZN is $37.54 B

What is the all time high annual gross profit for AstraZeneca?

AstraZeneca all-time high annual gross profit is $37.54 B

What is AstraZeneca annual gross profit year-on-year change?

Over the past year, AZN annual gross profit has changed by +$5.58 B (+17.47%)

What is AstraZeneca quarterly gross profit?

The current quarterly gross profit of AZN is $10.48 B

What is the all time high quarterly gross profit for AstraZeneca?

AstraZeneca all-time high quarterly gross profit is $10.76 B

What is AstraZeneca quarterly gross profit year-on-year change?

Over the past year, AZN quarterly gross profit has changed by +$1.09 B (+11.57%)

What is AstraZeneca TTM gross profit?

The current TTM gross profit of AZN is $41.42 B

What is the all time high TTM gross profit for AstraZeneca?

AstraZeneca all-time high TTM gross profit is $41.42 B

What is AstraZeneca TTM gross profit year-on-year change?

Over the past year, AZN TTM gross profit has changed by +$5.28 B (+14.62%)